Med-tech firms raising money in public or private financings, including: Brain Scientific, Nference, Ocular Therapeutix, Singlera Genomics, Viewpoint Molecular Targeting.

New hires and promotions in the med-tech industry, including: Irhythm Technologies, Neurocytonix, Pelvital, Tissium.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Astrazeneca, Beigene, Biogen, Biontech, Chugai, Codagenix, Cyxone, Daiichi Sankyo, Eisai, Gannex, Henlius, Ix, Open Orphan, Pfizer, Sinovac, Sorrento, Swedish Orphan Biovitrum, Takeda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Advaccine, Amarin, Astrazeneca, Biontech, Curevac, Daiichi Sankyo, Eli Lilly, EOC, Immutep, Incyte, Innovent, Inovio, Junshi, Kazia, Kintor, Mitsubishi Tanabe, Moderna, Novartis, Pfizer, Pharming, Tychan, Vicore.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3Sbio, Allarity, Anixa, Antengene, Applied Biomath, Arcus, Ascentage, Astrazeneca, Axcelead Drug Discovery, Biocytogen Boston, Bristol Myers Squibb, Cipla, Citius, Crescendo Biologics, Cure, Eisai, Eureka, Evommune, Fera, Fusion Antibodies, Halix, Hemoshear, Hummingbird, Hyundai, Immunitybio, Immunoprecise Antibodies, Inveniai, Kazia, Kyowa Kirin, Litevax, Moderna, Monopar, Nicox, Oncoceutics, Ontochem, Orgenesis, Overland, Pharmablock Sciences, Recce, Roche, Securabio, Sunshine, Synedgen, Taiho, Takeda, Vaccibody, Verseau, Virpax, Wuxi Biologics, Xencor.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Aurigene Discovery Technologies, CG Oncology, Curis, Cynata, Immunext, Kissei, Nuance, Scineuro.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Algo, Athenex, Astrazeneca, Can-Fite, Cyxone, Fortress, Genentech, IO Biotech, Nascent, Prometheus, Rafael, Takeda, Xentria.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Aditum, Alume, Anchiano, Anges, Annovis, Anteris, Assertio, Berg, Chemomab, Emendobio, Etherna, Faran, Frame, Greenwich, GT Gain, Harbour, Immunogen, Inovio, Jazz, Lantern, Nervgen, Novartis, Oncimmune, Opiant, Quantum Genomics, Redhill, Roche, Sanofi, Seelos, Seneca, Sensorion, Vtv .

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Anavex, Arca, Diamedica, Emalex, Erytech, FSD, Glycostem, Harmony, Hightide, Kadimastem, Kiniksa, Liminal, Mesoblast, Minoryx, Nektar, Nicox, Novan, Novartis, Palatin, Plus, Provention, TFF, Verastem, Zealand.

Biopharmas raising money in public or private financings, including: Addex, Alligator, Alx, Arvinas, Biocardia, Cellectis, Clarity, Havn, Idera, Ocular, Oncozenge, Oncternal, Protagonist, Proteostasis, Ripple, Seelos, Sellas, Sutro, Syndax, TG, Tryp, Westlake Village, Xenetic, Yumanity.